Time-in-range using continuous glucose monitoring (CGM) technology in the management of gestational diabetes (GDM)
If you are currently pregnant and have been diagnosed with gestational diabetes by a glucose tolerance test, you may qualify for this study. The purpose of this study is to learn about continuous glucose monitor (CGM) use during pregnancy, which may improve treatment decisions for your gestational diabetes.
The device may help manage your blood sugar levels every day and require you to have fewer blood sugar fingersticks using your blood sugar meter. The study duration will be through the postpartum period of your pregnancy. Your participation will involve wearing a CGM (blinded or real-time), completing food logs/health surveys, and blood draws. After you deliver your baby, we will also collect a sample of your baby’s umbilical cord blood, placenta samples, and newborn body measurements.
You may be eligible if you:
- Are pregnant
- Have been diagnosed with gestational diabetes by a glucose tolerance test
You may be compensated up to a total of $170.00 through the duration of the study.
Whom do I contact for more additional information?
To find out more information and to learn if you are qualified to participate, fill out the online form below or call the Maternal Fetal Medicine – Pregnancy Research Group at 503-418-1231 or email us at email@example.com We want you to help us advance women’s health research!